Juno therapeutics stock price history
Juno Therapeutics - Juno, a Bristol-Myers Squibb company Juno Therapeutics, Inc. is a Bristol-Myers Squibb company. If you would like to access information about Juno and its products and pipeline, please click here. JUNO THERAPEUTICS, INC. Historical Data - JUNO - ADVFN Mar 18, 2020 · Historical prices for JUNO THERAPEUTICS, INC. with share price and JUNO stock charts. Free real-time prices, and the most active stock market forums. JUNO Stock Quote - Juno Therapeutics, Inc. Stock Price Today Juno is a clinical-stage company that brings together three of the world’s leading cancer centers – Fred Hutchinson Cancer Research Center, Memorial Sloan-Kettering Cancer Center and Seattle Children’s Research Institute – in unique partnership to advance a broad pipeline of breakthrough immunotherapies. Juno Therapeutics (JUNO) Stock Analysis & News | Seeking Alpha
OXFORD BIOMED. share price (OXB), chart, recent trades, company Update 17 Mar 2020; License & Supply Agreement with Juno Therapeutics 17 Mar 2020.
Juno Therapeutics, Inc. (JUNO) Stock Charts - Stock News Juno Therapeutics, Inc. (JUNO) Stock Charts. JUNO Home; Celgene Corporation has completed the acquisition of Juno Therapeutics, Inc. Juno Therapeutics, Inc. (JUNO) Today's Latest Price: $86.96 USD. 0.09 (0.10%) Ratings History Chart. Free access to the full ratings history for JUNO. Sign up now! Top Stories View All. 3 Consumer Staple Moderna Therapeutics Debuts In Largest Biotech IPO ... Moderna Therapeutics crashed far below the price of its initial public offering on Friday amid what analysts expected to be the biggest biotech IPO in history.. X. Late Thursday, Moderna priced
Juno Therapeutics, Inc. (delisted) Share Price History ...
What's in Store for Juno Therapeutics (JUNO) in Q1 ... Juno Therapeutics, Inc. Price and EPS Surprise. Juno Therapeutics, Inc. Price and EPS Surprise | Juno Therapeutics, Inc. Quote. Factors at Play With no approved products in its portfolio, Juno does not generate any product revenue yet. Thus, investor focus will primarily be on the company's cash burn and pipeline updates.
Apr 19, 2016 · I nvestors in Juno Therapeutics Inc (Symbol: JUNO) saw new options begin trading this week, for the June 17th expiration. At Stock Options Channel, …
Immunize Juno Therapeutics Inc (JUNO) Stock With This ...
EnrichVideo is a smart video platform for businesses. EnrichVideo Platform combines user data, clear call to action buttons to create 1000's of personalized, …
5 Mar 2018 Juno Therapeutics stocks price quote with latest real-time prices, charts, financials, latest news, technical analysis and opinions. Presenting JUNO historical stock prices and CAGR performance. End price/ share: $86.96. Dividends collected/share: $0.00. Total return: 60.41%. Average Find the latest 1877 (JUNO) stock quote, history, news and other vital information to help you with your stock trading and investing. Discover historical prices for JUNO stock on Yahoo Finance. View daily, weekly or monthly format back to when 1877 stock was issued. View JUNO's stock price, price target, earnings, financials, forecast, insider trades , news, and SEC filings at MarketBeat. NASDAQ:JUNOJuno Therapeutics Stock Price, Forecast & News share. View Juno Therapeutics' earnings history. Real time Juno Therapeutics (JUNO) stock price quote, stock graph, news & analysis. Real-time trade and investing ideas on Juno Therapeutics JUNO from the largest community of traders and investors.
Jul 25, 2017 · The sale price was only $3 more than the biotech’s initial public offering in December 2014. Juno’s Top Holder Sells $216 Million in Stock. The top holder in Juno Therapeutics just bailed